Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting

Research output: Contribution to journal › Article › peer-review

16 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{ee69b3eb7cdd4cf59e41fb75c985547e,

title = "Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting",

author = "Michael Br{\"a}ndle and Gordon Goodall and Katrina Erny-Albrecht and Erland Erdmann and William Valentine",

year = "2009",

language = "English",

volume = "139",

pages = "173--184",

journal = "SWISS MEDICAL WEEKLY",

issn = "1424-7860",

publisher = "Schwabe und Co. AG",

number = "(11-12)",

}

TY - JOUR

T1 - Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss setting

AU - Brändle, Michael

AU - Goodall, Gordon

AU - Erny-Albrecht, Katrina

AU - Erdmann, Erland

AU - Valentine, William

PY - 2009

Y1 - 2009

UR - http://www.smw.ch/for-readers/archive/backlinks/?url=/docs/pdfcontent/smw-12381.pdf

M3 - Article

SN - 1424-7860

VL - 139

SP - 173

EP - 184

JO - SWISS MEDICAL WEEKLY

JF - SWISS MEDICAL WEEKLY

IS - (11-12)

ER -